Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease: Recommendation statement from the Canadian Task Force on Preventive Health Care

Coronary artery disease (CAD) is a leading cause of morbidity and death among North American women.[1][1],[2][2] Each year, 4 of every 10 deaths of women in Canada,[3][3] and up to 3.8 million days in hospital,[4][4] are due to heart disease and stroke. Prevention of cardiovascular disease through